Boston Scientific to buy Penumbra in deal valued at $14.5 billion
15/01/2026 12:04
Jan 15 (Reuters) - Boston Scientific BSX.N said on Thursday it will buy Penumbra PEN.N in a deal valued at about $14.5 billion. (Reporting by Mariam Sunny in Bengaluru) ((Mariam.ESunny@thomsonreuters.com;))
Recent news on Penumbra
See all newsPenumbra Inc reports results for the quarter ended June 30 - Earnings Summary
Penumbra Q2 revenue slightly beats estimates, helped by product segment increase
Brief: Penumbra Q2 Revenue USD 390.046 Million Vs. IBES Estimate USD 389 Million
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade